心得安治疗婴儿血管瘤应用进展(7)
[29]Zhang L，Wu HW，Yuan W，et al.Propranolol therapy for infantile hemangioma：our experience[J].Drug Des Devel Ther，2017，11：1401-1408.
[30]Mahon C，Heron G，Perkins D.Oral propranolol for infantile haemangioma may be associated with transient gross motor delay[J].Br J Dermatol，2018，178(6)：1443-1444.
[31]Tosoni A，Cutrone M，Dalle Carbonare M，et al.Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma： a case report[J].Ital J Pediatr，2017，43(1)：103-106.
[32]Bayart CB，Tamburro JE，Vidimos AT，et al.Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase： a retrospective noninferiority study[J].Pediatr Dermatol， 2017，34(4)：413-421.
[33]Burkey BW，Jacobs JA，Aziz H.Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma[J].J Pediatr Pharmacol Ther，2017，22(2)：124-127.
[34]5Baggio R，Le Treut C，Darrieux L，et al.Psoriasiform diaper rash possibly induced by oral propranolol in an 18-month-old girl with infantile hemangioma[J].Case Rep Dermatol，2016，8(3)：369-373.
[35]Furuta S，Sato H，Tsuji S，et al.Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication：a preliminary report[J].Pediatr Surg Int，2016，32(9)：857-862.
[36]Chen YZ，Bai N，Bi JH，et al.Propranolol inhibits the proliferation， migration and tube formation of hemangioma cells through HIF-1αdependent mechanisms[J].Braz J Med Biol Res，2017，50(12)：e6138.
[37]Dornhoffer JR，Wei T，Zhang H，et al.The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment[J].Pediatr Res，2017，82(1)：155-163.
[38]Wn?k A，Andrzejewska E，Kobos J，et al.Molecular and immunohistochemical expression of apoptotic proteins Bax，Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment[J].Immunol Lett，2017，185：27-31.
[39]Chang L，Lv D，Yu Z，et al.Infantile hemangioma：factors causing recurrence after propranolol treatment[J].Pediatr Res，2018，83(1)：175-182.
[40]Li D，Li P，Guo Z，et al.Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway[J].Int J Mol Med，2017，39(3)：757-763.
[收稿日期]2018-04-15 [修回日期]2018-06-20
編辑/李阳利, 百拇医药(李荟元)
[30]Mahon C，Heron G，Perkins D.Oral propranolol for infantile haemangioma may be associated with transient gross motor delay[J].Br J Dermatol，2018，178(6)：1443-1444.
[31]Tosoni A，Cutrone M，Dalle Carbonare M，et al.Cardiac arrest in a toddler treated with propranolol for infantile Hemangioma： a case report[J].Ital J Pediatr，2017，43(1)：103-106.
[32]Bayart CB，Tamburro JE，Vidimos AT，et al.Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase： a retrospective noninferiority study[J].Pediatr Dermatol， 2017，34(4)：413-421.
[33]Burkey BW，Jacobs JA，Aziz H.Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma[J].J Pediatr Pharmacol Ther，2017，22(2)：124-127.
[34]5Baggio R，Le Treut C，Darrieux L，et al.Psoriasiform diaper rash possibly induced by oral propranolol in an 18-month-old girl with infantile hemangioma[J].Case Rep Dermatol，2016，8(3)：369-373.
[35]Furuta S，Sato H，Tsuji S，et al.Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication：a preliminary report[J].Pediatr Surg Int，2016，32(9)：857-862.
[36]Chen YZ，Bai N，Bi JH，et al.Propranolol inhibits the proliferation， migration and tube formation of hemangioma cells through HIF-1αdependent mechanisms[J].Braz J Med Biol Res，2017，50(12)：e6138.
[37]Dornhoffer JR，Wei T，Zhang H，et al.The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment[J].Pediatr Res，2017，82(1)：155-163.
[38]Wn?k A，Andrzejewska E，Kobos J，et al.Molecular and immunohistochemical expression of apoptotic proteins Bax，Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment[J].Immunol Lett，2017，185：27-31.
[39]Chang L，Lv D，Yu Z，et al.Infantile hemangioma：factors causing recurrence after propranolol treatment[J].Pediatr Res，2018，83(1)：175-182.
[40]Li D，Li P，Guo Z，et al.Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway[J].Int J Mol Med，2017，39(3)：757-763.
[收稿日期]2018-04-15 [修回日期]2018-06-20
編辑/李阳利, 百拇医药(李荟元)